Literature DB >> 12426258

Pulmonary interstitial disease in Ig deficiency.

Valentin Popa1, Thomas V Colby, Stanley B Reich.   

Abstract

STUDY
OBJECTIVES: To determine the frequency and type of interstitial lung disease (ILD) in consecutive subjects with symptomatic Ig deficiency. PATIENTS: One hundred forty-eight consecutive subjects with repeated respiratory infections and Ig deficiency. MEASUREMENTS: Ig classes and IgG subclasses (IgGSCs), the response to vaccination, pulmonary function tests, chest radiography, CT scan, Ga scan and, when possible, BAL and lung biopsy.
RESULTS: Twenty-nine of 148 subjects (19 men and 10 women aged 18 to 72 years) had evidence of ILD. In 20 subjects, no cause of ILD was apparent. The remaining nine cases were ostensibly due to identifiable causes. Twenty subjects had IgGSC deficiency, 8 subjects had common variable immunodeficiency, and 1 subject had combined IgM plus IgGSC deficiency. No isotype deficiency was consistently related to a specific ILD. After administration of IV Ig, eight subjects, all with IgGSC deficiency, improved clinically, physiologically, radiologically, and occasionally histologically, regardless of immunologic or radiologic features. In this selective sample, the prevalence of ILD in consecutive subjects with recurrent respiratory infections and Ig deficiency (29 of 148 subjects; 19.6%) was higher than in the general population (0.8%; p < 0.05).
CONCLUSIONS: ILD in Ig deficiency is frequent and usually involves IgGSC deficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426258     DOI: 10.1378/chest.122.5.1594

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

2.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

3.  Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins.

Authors:  N Arish; R Eldor; Y Fellig; N Bogot; U Laxer; U Izhar; A Rokach
Journal:  Thorax       Date:  2006-12       Impact factor: 9.139

4.  From lymphocytic interstitial pneumonia to MALT lymphoma of lung: a case report with a 5-year diagnostic dilemma.

Authors:  Wei Wu; Jing Zhou; Li-Gai Di; Hui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 5.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

6.  Immunological and clinical profile of adult patients with selective immunoglobulin subclass deficiency: response to intravenous immunoglobulin therapy.

Authors:  F Abrahamian; S Agrawal; S Gupta
Journal:  Clin Exp Immunol       Date:  2009-12-14       Impact factor: 4.330

Review 7.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 8.  Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.

Authors:  Barbara Deconinck; Johny Verschakelen; Johan Coolen; Eric Verbeken; Geert Verleden; Wim Wuyts
Journal:  Lung       Date:  2012-11-13       Impact factor: 3.777

Review 9.  Pulmonary manifestations of primary immunodeficiency disorders in children.

Authors:  Milos Jesenak; Peter Banovcin; Barbora Jesenakova; Eva Babusikova
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.